DCTD Programs

Cancer Diagnosis Program
Cancer Imaging Program
Cancer Therapy Evaluation Program
Developmental Therapeutics Program
Radiation Research Program
Translational Research Program
Biometric Research Branch
Office of Cancer Complementary and Alternative Medicine

Last Updated: 04/06/07

James H. Doroshow, M.D., FACP
Director of the Division of Cancer Treatment and Diagnosis

Exploratory Investigational New Drug (IND) Studies

Clinical trials performed using an exploratory investigational new drug (IND) will facilitate targeted therapies entering early phase evaluation where the target can be carefully monitored. The goal of this new guidance is to safely shorten the timeline for drug development. As part of the DCTD-CCR collaboration, novel agents for high-priority targets originating from academic and other extramural researchers will be eligible to take advantage of intramural resources.

^ Back to Top

< Previous|Next >